The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A Meta-Analysis and Overview of The Literature on Treatment Options for Left-Sided Ulcerative Colitis and Ulcerative Proctitis
Abstract
OBJECTIVES: Therapeutic trials in left-sided ulcerative colitis (L-UC) and ulcerative proctitis (UP) have lacked control for medication type, dose, delivery, and duration of therapy. METHODS: All published therapeutic articles and abstracts in L-UC or UP from 1958-1997 were reviewed. Improvement, remission rates, and adverse events were recorded for all (ALL), placebo-controlled (PC) studies, and for PC studies passing quality assessment (QA) scoring. Meta-analysis was used where appropriate. RESULTS: Left-sided UC: For active disease, 67 studies (17 PC; 10 QA) were identified. Mesalamine enemas achieved remission in a duration but not a dose response (QA), with higher remission rates than steroid enemas (ALL) and clinical improvement rates superior to oral therapies (QA, ALL). Remission maintenance: 17 (six PC, six QA) studies were identified. Mesalamine therapies had comparable remission rates at 6 months, with a possible dose but not delivery effect. Mesalamine enema dosing intervals between QHS to Q3 days maintained efficacy. Reported adverse events were most common with oral sulfasalazine and dose-independent for mesalamine. Withdrawals from therapy were less than placebo, or < or =3%. Ulcerative proctitis: For active disease, 18 (nine PC, three QA) studies were identified. Mesalamine suppositories achieved clinical improvement and remission in a duration but not dose response, with higher rates of remission than topical steroids (ALL). Remission maintenance: three (three PC, two QA) studies were identified. Remission ranged from 75% to 90% (6 months) and 61-90% (12 months) for mesalamine agents. Reported adverse events were most common for mesalamine foam (8%). Withdrawals from therapy were <2%. CONCLUSIONS: In L-UC and UP, the efficacy and side-effect profile of topical mesalamine are dose independent and superior to oral therapies and topical steroids. Economic analysis suggests that use of these agents will also result in an overall decrease in patient costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
(2011) · Hepatogastroenterology · doi:10.5754/hge11125 · Cited by 2,450
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T., Sparr, J., Prokipchuk, E., & Borgen, L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90621-4 · Cited by 677
Thompson, S. G., & Pocock, S. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91975-z · Cited by 487
Peto, R. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060306 · Cited by 409 · cited 1×
“of 30% (86), and the concealment of treatment allocation”
Background(1995) · Gastroenterology · doi:10.1016/0016-5085(95)27940-7 · Cited by 322
Hanauer, S., SCHWARTZ, J., ROBINSON, M. G., Roufail, W. M., Arora, S., Cello, J. P., & Safdi, M. A. (1993) · PubMed · Cited by 266
Self-citationSutherland, L. R., May, G. R., & Shaffer, E. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00009 · Cited by 230
Predictive ability of meta-analyses of randomised controlled trials
Villar, J., Carroli, G., & Belizán, J. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90646-0 · Cited by 225
Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis
MARSHALL, J. K., & IRVINE, E. J. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00384.x · Cited by 194
Azodisal sodium in the treatment of ulcerative colitis
Sandberg-Gertzén, H., Järnerot, G., & Kraaz, W. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90882-6 · Cited by 187
Problems induced by meta‐analyses
Chalmers, T. C. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100618 · Cited by 144
Pentasa UC Maintenance Study Group, Miner, P. B., Hanauer, S. B., ROBINSON, M. G., Schwartz, J., & Arora, S. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065413 · Cited by 140
Self-citationBudesonide versus prednisolone retention enemas in active distal ulcerative colitis
Löfberg, R., Thomsen, O. Ø., Langholz, E., Schiöler, R., Danielsson, Å., Suhr, O. B., Graffner, H., Påhlman, L., Matzen, P., Møller-Petersen, J., et al. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00340.x · Cited by 103
Farup, P. G., Hovde, Ø., Halvorsen, F.-A., Raknerud, N., & Brodin, U. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509093256 · Cited by 93
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Rao, S. S., Dundas, S. A. C., Holdsworth, C. D., Cann, P. A., Palmer, K. R., & Corbett, C. L. (1989) · Gut · doi:10.1136/gut.30.5.675 · Cited by 79
Ruddell, W. S., Dickinson, R., Dixon, M. F., & Axon, A. T. R. (1980) · Gut · doi:10.1136/gut.21.10.885 · Cited by 75
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Travis, S. P. L., Tysk, C., de Silva, H. J., Sandberg–Gertzén, H., Jewell, D. P., & Järnerot, G. (1994) · Gut · doi:10.1136/gut.35.9.1282 · Cited by 74
D’Arienzo, A., Panarese, A., D’Armiento, F. P., Lancia, C., Quattrone, P., Giannattasio, F., Boscaino, A., & Mazzacca, G. (1990) · PubMed · Cited by 73
Friedman, L. S., Richter, J. M., Kirkham, S. E., DeMonaco, H. J., & May, R. (1986) · PubMed · Cited by 71
Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis
Campieri, M., Paoluzi, P., D'Albasio, G., Brunetti, G., Pera, A., & Barbara, L. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01296108 · Cited by 66
Treatment of Left-Sided Ulcerative Colitis with 4-Aminosalicylic Acid Enemas
Ginsberg, A. L., BECK, L. S., McINTOSH, T. M., & NOCHOMOVITZ, L. E. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-195 · Cited by 59
5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada
Sutherland, L. R., & Martin, F. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01312466 · Cited by 53
Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis
Porro, G. B., Prantera, C., Campieri, M., Petrillo, M., Campanini, M. C., Gionchetti, P., Grandinetti, G., Mangiarotti, R., Brunetti, G., & Ranzi, T. (1994) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199402000-00007 · Cited by 51
Treatment of distal ulcerative colitis with beclomethasone enemas
Bansky, G., Bühler, H., Stamm, B., Häcki, W. H., Buchmann, P., & Müller, J. (1987) · Diseases of the Colon & Rectum · doi:10.1007/bf02556177 · Cited by 50
Oral fluticasone propionate in active distal ulcerative colitis.
Angus, P. W., Snook, J. A., Reid, M., & Jewell, D. P. (1992) · Gut · doi:10.1136/gut.33.5.711 · Cited by 46
A Controlled Trial of Beclomethasone Versus Betamethasone Enemas in Distal Ulcerative Colitis
Halpern, Z., Sold, O., Baratz, M., Konikoff, F. M., Halak, A., & Gilat, T. (1991) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199102000-00009 · Cited by 44
Mulder, C. J. J., Endert, E., van der Heide, H., Houthoff, H. J., Wiersinga, W. M., Wiltink, E. H. H., & Tytgat, G. N. J. (1989) · PubMed · Cited by 30
Proctocolitis unresponsive to conventional therapy
McPhee, M. S., Swan, J. T., Biddle, W. L., & Greenberger, N. J. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01312469 · Cited by 29
Marteau, P. R., & Halphen, M. (1995) · PubMed · Cited by 7
Dose ranging study of budesonide enema in active distal ulcerative colitis
Hanuer, S. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)27637-8 · Cited by 4
Cited by
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Guidelines for the management of inflammatory bowel disease in adults
Carter, M. J., Lobo, A. J., & Travis, S. P. L. (2004) · Gut · doi:10.1136/gut.2004.043372 · Cited by 1,083
Metadata
- Authors
- Cohen, R. D., Woseth, D. M., Thisted, R. A., & Hanauer, S. B.
- Venue
- American Journal of Gastroenterology
- Published
- 2000-05
- Volume
- 95
- Issue
- 5
- Pages
- 1263-1276
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2082034492
- Cited by
- 277
- References
- 34
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.